RenovoRx H.C. Wainwright Presentation to Highlight RenovoCath Growth and Phase III TIGeR-PaC Timeline

ConferenceRenovoCathNeutral

AI Analysis

Summary

RenovoRx will present at H.C. Wainwright conference highlighting RenovoCath growth and Phase III TIGeR-PaC trial timeline. This is a routine conference presentation announcement.

Clinical Trial Data

Phase

Phase_3

Importance:3/10

Sentiment:

0.00

Phase 3clinical trialconference presentationTIGeR-PaC

Related Companies

$RNXT

Read the original article

Published by yahoo_finance on September 2, 2026 2:39 PM

Read Original